Quality of care provided by hospice and palliative care agencies depends on a thorough understanding of the patient, the family, their history, and current risk factors. It is therefore imperative for social workers and other providers in these settings to assess patients and caregivers for substance use disorders and potential for substance misuse.
Objective:
We aimed to examine how hospice social workers in the United States screen and assess for alcohol and substance use and risk of medication diversion among patients and family caregivers.
Design/Measurements:
Using a cluster random sample of U.S. Medicare-certified hospices, we reviewed blank copies of psychosocial assessments used by hospice social workers from 105 agencies. We conducted systematic content analyses of these assessments, identifying and examining all items related to substance use or addiction.
Results:
Over two-thirds (68%) of agencies assessed substance use by patient and/or family members. Assessments tended to focus broadly on whether substance misuse was a current problem for the patient or his/her primary caregivers. Assessments were not standardized instruments and did not differentiate between drug types. No assessments directly addressed potential diversion of pain medications. Larger hospices serving more patients per day were more likely to include substance use content in their assessments.
Conclusions:
We recommend that hospice care providers implement structured substance use screening focused on both the patients and family. To stem the public health impact of prescription opioid misuse, we recommend adoption of structured screening instruments to evaluate drug diversion risk.
Get full access to this article
View all access options for this article.
References
1.
SmithAK, CenzerIS, KnightSJ, et al.: The epidemiology of pain during the last 2 years of life. Ann Intern Med, 2010; 153:563–569.
2.
WeissSC, EmanuelLL, FaircloughDL, et al.: Understanding the experience of pain in terminally ill patients. Lancet, 2001; 357:1311–1315.
3.
DrewDJ, St. MarieBJ: Pain in critically ill patients with substance use disorder or long-term opioid use for chronic pain. AACN Adv Crit Care, 2011; 22:238–254.
4.
NewshanG: Pain management in the addicted patient: Practical considerations. Nurs Outlook, 2000; 48:81–85.
5.
St MarieB: Health care experiences when pain and substance use disorder coexist: “Just because I'm an addict doesn't mean I don't have pain.”. Pain Med, 2014; 15:2075–2086.
6.
WeathermonR, CrabbDW: Alcohol and medication interactions. Alcohol Res Health, 1999; 23:40.
7.
MerlinJS, YoungSR, AzariS, et al.: Management of problematic behaviours among individuals on long-term opioid therapy: Protocol for a Delphi study. BMJ Open, 2016; 6:e011619.
8.
BaborT, CampbellR, RoomR, et al.: Lexicon of Alcohol and Drug Terms. Geneva: World Health Organization, 1994.
9.
GilsonAM, RyanKM, JoransonDE, et al.: A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. J Pain Symptom Manage, 2004; 28:176–188.
10.
StoneR: Defining family caregivers of the elderly: Implications for research and public policy. Gerontologist, 1991; 31:724–725.
11.
GrantBF, GoldsteinRB, SahaTD, et al.: Epidemiology of DSM-5 alcohol use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry, 2015; 72:757–766.
12.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Publishing, 2013.
13.
DawsonDA, GoldsteinRB, SahaTD, et al.: Changes in alcohol consumption: United States, 2001–2002 to 2012–2013. Drug Alcohol Depend, 2015; 148:56–61.
14.
HuangB, DawsonDA, StinsonFS, et al.: Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry, 2006; 67:1062–1073.
15.
Substance Abuse And Mental Health Services Administration: Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014.
16.
PelucchiC, TramacereI, BoffettaP, et al.: Alcohol consumption and cancer risk. Nutr Cancer, 2011; 63:983–990.
17.
ValdiserriR, KhalsaJ, DanC, et al.: Confronting the emerging epidemic of HCV infection among young injection drug users. Am J Public Health, 2014; 104:816–821.
18.
GarfeinRS, VlahovD, GalaiN, et al.: Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health, 1996; 86:655–661.
19.
PassikSD, TheobaldDE: Managing addiction in advanced cancer patients: Why bother?. J Pain Symptom Manage, 2000; 19:229–234.
20.
ParsonsHA, Delgado-GuayMO, El OstaB, et al.: Alcoholism screening in patients with advanced cancer: Impact on symptom burden and opioid use. J Palliat Med, 2008; 11:964–968.
21.
FerrellB, ConnorSR, CordesA, et al.: The national agenda for quality palliative care: The National Consensus Project and the National Quality Forum. J Pain Symptom Manage, 2007; 33:737–744.
22.
CagleJ, AltilioT: The social work role in pain and symptom management. In: AtilioT, Otis-GreenS (eds). Oxford Textbook of Palliative Social Work. New York: Oxford University Press, 2011, pp. 271–286.
23.
RomemA, TomSE, BeaucheneM, et al.: Pain management at the end of life: A comparative study of cancer, dementia, and chronic obstructive pulmonary disease patients. Palliat Med, 2015; 29:464–469.
24.
SeraL, McPhersonML, HolmesHM: Commonly prescribed medications in a population of hospice patients. Am J Hosp Palliat Med, 2014; 31:126–131.
25.
WachholtzA, FosterS, CheatleM: Psychophysiology of pain and opioid use: Implications for managing pain in patients with an opioid use disorder. Drug Alcohol Depend, 2015; 146:1–6.
26.
KirshKL, PassikSD: Palliative care of the terminally ill drug addict. Cancer Invest, 2006; 24:425–431.
27.
PassikSD, KirshKL: Opioid therapy in patients with a history of substance abuse. CNS Drugs, 2004; 18:13–25.
28.
UnickGJ, RosenblumD, MarsS, et al.: Intertwined epidemics: National demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993–2009. PLoS One, 2013; 8:e54496.
29.
MartinsSS, KeyesKM, StorrCL, et al.: Birth-cohort trends in lifetime and past-year prescription opioid-use disorder resulting from nonmedical use: Results from two national surveys. J Stud Alcohol Drugs, 2010; 71:480–487.
30.
ComptonWM, VolkowND: Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug Alcohol Depend, 2006; 81:103–107.
31.
BrueraE, MoyanoJ, SeifertL, et al.: The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage, 1995; 10:599–603.
32.
DevR, ParsonsHA, PallaS, et al.: Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients. Cancer, 2011; 117:4551–4556.
33.
BarclayJS, OwensJE, BlackhallLJ: Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen. Supportive Care Cancer, 2014; 22:1883–1888.
34.
National Consensus Project for Quality Palliative Care: Clinical Practice Guidelines for Quality Palliative Care. Pittsburgh, PA: National Consensus Project for Quality Palliative Care, 2013.
35.
BlackhallL, AlfsonE, BarclayJ: Screening for substance abuse and diversion in Virginia hospices. J Palliat Med, 2011; 41:228–229.
36.
TanPD, BarclayJS, BlackhallLJ: Do palliative care clinics screen for substance abuse and diversion? Results of a national survey. J Palliat Med, 2015; 18:752–757.
37.
ChildersJW, ArnoldRM: “I feel uncomfortable ‘calling a patient out’”: Educational needs of palliative medicine fellows in managing opioid misuse. J Pain Symptom Manage, 2012; 43:253–260.
38.
CagleJG, OsteenP, SaccoP, et al.: Psychosocial assessment by hospice social workers: A content review of instruments from a national sample. J Pain Symptom Manage, 2016; 53:40–48.
39.
United States Census Bureau: Census Regions and Divisions of the United States. www.census.gov/geo/www/us_regdiv.pdf (Last accessed November1, 2016).
40.
HumeniukR, Henry-EdwardsS, AliR, et al.: The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Manual for Use in Primary Care. Geneva, Switzerland: World Health Organization, 2010.
41.
BaborTF, Higgins-BiddleJ, SaundersJB, et al.: The Alcohol Use Disorders Identification Test: Guidelines For Use in Primary Care. 2 ed. Geneva, Switzerland: World Health Organization, 2001.
42.
HansonLC, ScheunemannLP, ZimmermanS, et al.: The PEACE project review of clinical instruments for hospice and palliative care. J Palliat Med, 2010; 13:1253–1260.
43.
WHO ASSIST Working Group: The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Development, reliability and feasibility. Addiction, 2002; 97:1183–1194.
44.
BaborTF, McReeBG, KassebaumPA, et al.: Screening, Brief Intervention, and Referral to Treatment (SBIRT): Toward a public health approach to the management of substance abuse. Subst Abus, 2007; 28:7.
45.
SaitzR, GalanterM.: Alcohol/drug screening and brief intervention: Advances in evidence-based practice. Subst Abus, 2007; 28.
46.
AgerwalaSM, McCance-KatzE: Integrating screening, brief intervention, and referral to treatment (SBIRT) into clinical practice settings: A brief review. Journal of Psychoactive Drugs, 2012; 44:307–317.
47.
MillerWR, RollnickS: Motivational Interviewing: Helping People Change. New York: Guilford, 2013.
48.
VolkowND, McLellanTA: Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA, 2011; 305:1346–1347.
49.
CarmichaelA-N, MorganL, Del FabbroE: Identifying and assessing the risk of opioid abuse in patients with cancer: An integrative review. Subst Abuse Rehabil, 2016; 7:71–79.
50.
Al-AtiyyatNMH: Patient-related barriers to effective cancer pain management. J Hosp Palliat Nurs, 2008; 10:198–204.
51.
OliverDP, Wittenberg-LylesE, DemirisG, et al.: Barriers to pain management: Caregiver perceptions and pain talk by hospice interdisciplinary teams. J Pain Symptom Manage, 2008; 36:374–382.
52.
CagleJG, ZimmermanS, CohenLW, et al.: EMPOWER: An intervention to address barriers to pain management in hospice. J Pain Symptom Manage, 2015; 49:1–12.
